Plain-English translation of NCT06286397 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This research trial is testing whether clascoterone, a topical cream, can help treat pilonidal sinus disease—a condition where hair and skin cells become trapped, causing pain, drainage, and infection in the area between the buttocks. You would apply the medication twice daily for 12 weeks. Half of participants will receive the active cream, and half will receive a placebo (a cream that looks and feels identical but has no active ingredient), so researchers can fairly measure how well the treatment works.
Pilonidal sinus disease can be painful and bothersome, and many patients end up needing surgery to manage it. This trial explores whether this medication applied to the skin could help reduce symptoms and potentially avoid the need for surgery.
You likely qualify if…
You likely don't qualify if…
You would visit the colorectal surgery clinic at the start and then at weeks 4, 8, and 12—four visits total over three months. At each visit, doctors will take photographs of the affected area, ask you questions about your symptoms and quality of life, and check for any side effects. Between visits, you'll apply the cream (either the active treatment or placebo) to the affected area twice daily as instructed. The study is "blinded," meaning neither you nor the researchers will know whether you're receiving the active cream or placebo until the trial ends.
AI-generated summary from trial data · Aug 29, 2026 · Not medical advice
United States